Tumor Markers

CA-125 — What Your Blood Test Result Means

ScanHealth Learn Tumor Markers CA-125

The Ovarian Cancer Marker

CA-125 is a protein found on the surface of ovarian cancer cells and some normal tissues. It's the most widely used ovarian cancer marker, but it's frustratingly nonspecific—endometriosis, fibroids, pelvic inflammatory disease, menstruation, pregnancy, and even liver disease can elevate it. Its best use is MONITORING known ovarian cancer, not screening.

What is CA-125?

CA-125 (cancer antigen 125) is a mucin-type glycoprotein expressed on coelomic epithelium. Normal: <35 U/mL. Elevated in ~80% of advanced ovarian cancers but only ~50% of stage I. Very nonspecific in premenopausal women. Best for monitoring, not screening.

What High CA-125 Means

In a postmenopausal woman with a pelvic mass: very concerning for ovarian cancer. In a premenopausal woman: much more likely to be endometriosis, fibroids, or other benign causes. CA-125 >200 with a complex pelvic mass in a postmenopausal woman is highly suspicious.

Common symptoms:

Often asymptomatic early (ovarian cancer is "the silent killer") · Bloating, pelvic pain, difficulty eating, urinary frequency · Advanced: ascites, weight loss, bowel obstruction

What Low CA-125 Means

Reassuring in the context of ovarian cancer surveillance. Doesn't exclude early-stage ovarian cancer.

Common symptoms:

No symptoms

Why It Matters

When normal:

Monitors ovarian cancer treatment response and recurrence

Helps evaluate pelvic masses (especially postmenopausal)

ROMA (Risk of Ovarian Malignancy Algorithm) combines CA-125 + HE4 for better specificity

Risks if abnormal:

Not recommended for general screening (USPSTF)

Very nonspecific in premenopausal women

Normal CA-125 doesn't exclude early ovarian cancer

Many benign causes of elevation

What Can Cause Abnormal Levels?

Ovarian Cancer

30% likely

Elevated in 80% of advanced ovarian cancer. Better marker in postmenopausal women.

Endometriosis

35% likely

Very common benign cause of CA-125 elevation in premenopausal women.

Menstruation

CA-125 fluctuates with the menstrual cycle—higher during menses.

Pelvic Inflammatory Disease

Peritoneal inflammation elevates CA-125.

Fibroids

Uterine fibroids mildly elevate CA-125.

Liver Disease/Ascites

Peritoneal fluid and liver disease elevate CA-125.

Other Cancers

Endometrial, fallopian tube, peritoneal, pancreatic, lung, breast.

What You Can Do

CA-125 is not recommended for screening in average-risk women

Impact: Too many false positives—causes unnecessary surgery \u00B7 Timeline: N/A

If mildly elevated in premenopausal woman: likely benign, repeat after period

Impact: Menstruation elevates CA-125 \u00B7 Timeline: 4-6 weeks

If lifestyle changes aren't enough:

ROMA algorithm (CA-125 + HE4) for pelvic mass evaluation

Impact: Better specificity than CA-125 alone \u00B7 Timeline: With mass workup

Pelvic ultrasound if CA-125 elevated in appropriate clinical context

Impact: Evaluates for pelvic pathology \u00B7 Timeline: As indicated

Recommended retest: Cancer monitoring: per treatment protocol. Elevated without cancer: repeat in 4-6 weeks.

Related Markers

he4 cea afp ldh ca199
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor for diagnosis and treatment.

Got your blood test report?

Upload your PDF and understand ALL your markers in 2 minutes. Plain language. Traffic light status. No medical jargon.

Analyze My Report — Free

First report is free. No credit card needed.

Browse all markers